Feds mull covering Alzheimer’s test that uses Lilly’s Amyvid
The $3,000 test for the first time accurately identifies the signature brain plaques of the debilitating disease.
Health Care
Articles
St. Vincent Health eliminating about 865 jobs in Indiana
It was not clear how many workers were losing their jobs in the Indianapolis area. However, people familiar with the cuts said the reductions were heavy in the administrative ranks, and many of those jobs are on the city’s north side.
Doctors caught in cost-cutting crossfire
Physicians employed by Indianapolis-area hospitals are likely to see their pay cut in the next few years unless the hospitals find new ways to be significantly more efficient.
Answer on Indiana Medicaid plan could take some time
The head of the state Family and Social Services Administration said Tuesday that the federal government is expected to approve an extension of the Healthy Indiana Plan, but a request to use the plan for an Indiana Medicaid expansion could take much longer.
Lilly wins patent lawsuit on J&J Alzheimer’s research
A patent held by J&J’s Janssen Alzheimer Immunotherapy Research & Development unit isn’t valid, Judge Richard Arnold said in a ruling in London Tuesday.
Lilly’s experimental diabetes drug helps patients lose weight
Lilly’s drug, if approved, may be a significant competitor to Novo Nordisk A/S’s Victoza, which generated $1.64 billion in 2012.
Indiana tangles with shortage of rural doctors
The federal health care overhaul is expected to exacerbate problems regarding access to care in rural Indiana communities where is there is already a shortage of doctors and other health care providers.
Startup pitching app as money-saver for hospitals
The founder and CEO of Diagnotes Inc. thinks his company’s mobile app can help doctors run their office from their iPhones—just as many other professionals have been doing for years.
Lilly’s Zyprexa injection probed by FDA after deaths
Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug.
Drugmakers may face ‘pay for delay’ suits, high court rules
Drug companies like Eli Lilly and Co. can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.
Lilly to take over development of diabetes drug
Eli Lilly and Co. will pay Canadian drug developer Transition Therapeutics Inc. at least $7 million and up to as much as $247 million to take over the development of a potential diabetes treatment.
Lilly halts trial of experimental Alzheimers drug
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a statement.
Governments helped fuel nursing-facility developer’s rise
Carmel-based Mainstreet Property Group has built 13 nursing homes in Indiana and Illinois since 2008. Six of the dozen Indiana properties benefited from municipal-backed credit or tax breaks, and a seventh received a reduced-impact fee. Mainstreet also received $345,000 in state economic incentives.
New law lets pharmacists provide pneumonia, HPV vaccines
Starting July 1, pharmacists will be able to offer a much wider variety of immunizations to customers, in an effort from lawmakers to make health care more accessible.
Caponi to step down as St. Vincent system CEO
After overseeing 15 years of massive growth via mergers, Vince Caponi will become an executive of St. Vincent Health’s parent organization.
Planned Parenthood affiliates in Indiana, Kentucky to merge
The new not-for-profit organization is expected to be named Planned Parenthood of Indiana and Kentucky—or PPINK—and continue to operate the 28 existing health centers between the two states.
IU Health agrees to sell occupational health clinics
US HealthWorks Medical Group, which specializes in workers’ compensation cases, agreed in May to acquire the eight clinics. The deal is expected to close before the end of June.
Indiana Blood Center cuts staff, scales back work
The not-for-profit blood center announced Monday that demand from hospitals has fallen 24 percent over the past year, forcing it to take steps that also include freezing management salaries, eliminating 45 positions and discontinuing a therapeutic phlebotomy program.
Drug sold by Lilly tops Avastin in colon cancer survival study
Patients who got Erbitux together with chemotherapy as a first-line treatment lived about four months longer than those who got Avastin with chemotherapy, according to the 592-person study.
Mainstreet plans $9.2M nursing home on northwest side
The 65,000-square-foot nursing-home and assisted-living facility would feature an Internet cafe, movie theaters and restaurant-style dining with an on-site chef.